nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefamandole—SLC22A11—Methotrexate—multiple sclerosis	0.304	0.34	CbGbCtD
Cefamandole—SLC22A7—Methotrexate—multiple sclerosis	0.29	0.324	CbGbCtD
Cefamandole—SLC22A8—Methotrexate—multiple sclerosis	0.177	0.198	CbGbCtD
Cefamandole—SLC22A6—Methotrexate—multiple sclerosis	0.123	0.138	CbGbCtD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—EOMES—multiple sclerosis	0.0105	0.153	CbGpPWpGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—STAT4—multiple sclerosis	0.005	0.0728	CbGpPWpGaD
Cefamandole—PTPN7—Ras signaling in the CD4+ TCR pathway—MAPK1—multiple sclerosis	0.00463	0.0674	CbGpPWpGaD
Cefamandole—Cefazolin—PON1—multiple sclerosis	0.00381	0.101	CrCbGaD
Cefamandole—Cefmetazole—SLC15A2—multiple sclerosis	0.00358	0.0952	CrCbGaD
Cefamandole—SLC22A7—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00339	0.0493	CbGpPWpGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—CD8A—multiple sclerosis	0.00331	0.0482	CbGpPWpGaD
Cefamandole—Cefuroxime—SLC15A2—multiple sclerosis	0.00303	0.0806	CrCbGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—IL2RA—multiple sclerosis	0.00299	0.0435	CbGpPWpGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—HLA-A—multiple sclerosis	0.00295	0.043	CbGpPWpGaD
Cefamandole—Azidocillin—SLC15A2—multiple sclerosis	0.00267	0.0709	CrCbGaD
Cefamandole—Ceftazidime—SLC15A2—multiple sclerosis	0.00246	0.0655	CrCbGaD
Cefamandole—Cefaclor—SLC15A2—multiple sclerosis	0.0024	0.0637	CrCbGaD
Cefamandole—Cefradine—SLC15A2—multiple sclerosis	0.0023	0.0611	CrCbGaD
Cefamandole—Cefadroxil—SLC15A2—multiple sclerosis	0.00217	0.0578	CrCbGaD
Cefamandole—Ampicillin—SLC15A2—multiple sclerosis	0.00204	0.0542	CrCbGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—IFNG—multiple sclerosis	0.00197	0.0287	CbGpPWpGaD
Cefamandole—Cefotaxime—SLC15A2—multiple sclerosis	0.00189	0.0504	CrCbGaD
Cefamandole—Ceftriaxone—SLC15A2—multiple sclerosis	0.00187	0.0497	CrCbGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—IL2—multiple sclerosis	0.00175	0.0255	CbGpPWpGaD
Cefamandole—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.0017	0.0247	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—BDNF—multiple sclerosis	0.00166	0.0242	CbGpPWpGaD
Cefamandole—Cefalotin—SLC15A2—multiple sclerosis	0.00164	0.0435	CrCbGaD
Cefamandole—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00154	0.0224	CbGpPWpGaD
Cefamandole—Cephalexin—SLC15A2—multiple sclerosis	0.00149	0.0395	CrCbGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—FAS—multiple sclerosis	0.00142	0.0207	CbGpPWpGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—MAPK1—multiple sclerosis	0.00134	0.0195	CbGpPWpGaD
Cefamandole—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00129	0.0188	CbGpPWpGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—TNF—multiple sclerosis	0.00128	0.0186	CbGpPWpGaD
Cefamandole—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00119	0.0172	CbGpPWpGaD
Cefamandole—Cefotetan—ALB—multiple sclerosis	0.00116	0.0307	CrCbGaD
Cefamandole—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00108	0.0157	CbGpPWpGaD
Cefamandole—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00108	0.0156	CbGpPWpGaD
Cefamandole—SLC22A11—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00102	0.0148	CbGpPWpGaD
Cefamandole—Cefpiramide—ALB—multiple sclerosis	0.001	0.0267	CrCbGaD
Cefamandole—SLC22A7—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000923	0.0134	CbGpPWpGaD
Cefamandole—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000904	0.0132	CbGpPWpGaD
Cefamandole—Cefonicid—ALB—multiple sclerosis	0.000875	0.0233	CrCbGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—IL1B—multiple sclerosis	0.000832	0.0121	CbGpPWpGaD
Cefamandole—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000775	0.0113	CbGpPWpGaD
Cefamandole—Cefmetazole—ALB—multiple sclerosis	0.000771	0.0205	CrCbGaD
Cefamandole—SLC22A11—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000771	0.0112	CbGpPWpGaD
Cefamandole—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000754	0.011	CbGpPWpGaD
Cefamandole—SLC22A7—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000699	0.0102	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—MYC—multiple sclerosis	0.000648	0.00943	CbGpPWpGaD
Cefamandole—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000647	0.00942	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—TGFB1—multiple sclerosis	0.000647	0.00941	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—MAPK1—multiple sclerosis	0.000634	0.00923	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—TNF—multiple sclerosis	0.000604	0.00879	CbGpPWpGaD
Cefamandole—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000588	0.00855	CbGpPWpGaD
Cefamandole—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000538	0.00784	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000517	0.00752	CbGpPWpGaD
Cefamandole—Cefoperazone—ALB—multiple sclerosis	0.000516	0.0137	CrCbGaD
Cefamandole—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000491	0.00714	CbGpPWpGaD
Cefamandole—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000489	0.00711	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000469	0.00682	CbGpPWpGaD
Cefamandole—Ampicillin—ALB—multiple sclerosis	0.000439	0.0117	CrCbGaD
Cefamandole—Cefazolin—ALB—multiple sclerosis	0.000424	0.0113	CrCbGaD
Cefamandole—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000411	0.00598	CbGpPWpGaD
Cefamandole—Ceftriaxone—ALB—multiple sclerosis	0.000402	0.0107	CrCbGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000394	0.00574	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000392	0.0057	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000355	0.00517	CbGpPWpGaD
Cefamandole—Cefalotin—ALB—multiple sclerosis	0.000352	0.00936	CrCbGaD
Cefamandole—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000343	0.00499	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000329	0.00479	CbGpPWpGaD
Cefamandole—Cephalexin—ALB—multiple sclerosis	0.00032	0.00851	CrCbGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00031	0.00451	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000299	0.00435	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000281	0.00409	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000274	0.00398	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000249	0.00363	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000248	0.00361	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000236	0.00344	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000209	0.00304	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000197	0.00287	CbGpPWpGaD
Cefamandole—SLC22A11—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000194	0.00282	CbGpPWpGaD
Cefamandole—SLC22A7—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000176	0.00256	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000174	0.00253	CbGpPWpGaD
Cefamandole—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000148	0.00215	CbGpPWpGaD
Cefamandole—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000123	0.0018	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.85e-05	0.00143	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.94e-05	0.0013	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.51e-05	0.00109	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.27e-05	0.000913	CbGpPWpGaD
